Serologic Testing and Genomic Analysis of Autoimmune ImmuneMediated and Rheumatic Patients with COVID-19 (SAGA)

Go Back to All Clinical Trials

Serologic Testing and Genomic Analysis of Autoimmune ImmuneMediated and Rheumatic Patients with COVID-19 (SAGA)

Brief description of study

The purpose of this study is to obtain blood samples and nasal swab samples of patients with autoimmune and inflammatory diseases to see if certain factors affect formation of antibodies against SARS-CoV-2, the virus causing COVID-19. Antibodies are proteins of the immune system that form against foreign invaders in the body (such as viruses). This study also aims to look at genes that might influence patients’ risk for developing COVID-19 and having severe disease. DNA is the material that makes up your genes. All living things are made of cells. Genes are the part of cells that contain the instructions which tell our bodies how to grow and work, and determine physical characteristics such as hair and eye color. Genes are passed from parent to child.

Clinical Study Identifier: s20-01078

Principal Investigator: Jose U Scher.

Other Investigators: Brian Daniel Jaros, Jordan E Axelrad, Shannon Chang, Sergei B Koralov, Ramin Herati, Simon J Hong, Rebecca Barbara Blank, Rebecca Haberman, Andrea L. Neimann, David P Hudesman, Di Yan.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies